Prostate Cancer

"RANKL is a protein which tells tumor cells to come to it," said Professor Josef Penninger, of the Austrian Academy of Sciences in Vienna.

"It sits on the bones and when tumor cells circulate in the body then RANKL attracts them into the bones," "Since there are novel inhibitors of RANKL far along in clinical development, the idea is that people who have cancer that is known to spread to bone can start taking this drug when they are diagnosed," said the lead author of the study.

Source: www.msnbc.msn.com WebReporter: lurker lurker Recommendation: ASSESS this news: BLOCK this news.

Reason: Assessment: very goodgoodmoderatebadvery bad Reason: entertaininginformativeinterestingup to datewell summarised incompletenews out of datenot well formulatedtitle is misleadingtoo many errorsuninterestingwrong channel belongs to Soft News!

belongs to Tips&Tricks!

Falsely reportedmasked advertisingnews appears twicenews is a hoaxnews is an opinionnews is illegal!

news only copiedwrong source What's Your Opinion?

About us Free Newsticker General Terms & Conditions Copyright ©2004 GoNamic GmbH, Contact: info@shortnews.com Usenet ShortWin ...

Read more...